SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

ANX takeover rumor confirmed by FoxBusiness (link)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Lt_investor Member Profile
 
Followed By 16
Posts 1,880
Boards Moderated 0
Alias Born 10/18/08
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/6/2016 8:17:12 AM
Mast Therapeutics Reports First Quarter 2016 Financial Results And Recent Highlights "PR Newswire (US)" - 5/6/2016 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/28/2016 4:30:09 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/28/2016 4:22:06 PM
Mast Therapeutics Announces Agreement For Phase 2 Study Of AIR001 To Be Conducted By The Heart Failure Clinical Research Netw... "PR Newswire (US)" - 4/13/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/5/2016 5:01:40 PM
Results Of Vepoloxamer Nonclinical Studies In Advanced Heart Failure Presented At American College Of Cardiology 65th Annual ... "PR Newswire (US)" - 4/4/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/25/2016 5:05:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/14/2016 8:21:40 AM
Mast Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results "PR Newswire (US)" - 3/14/2016 8:00:00 AM
Mast Therapeutics To Present At Cowen And Company 36th Annual Health Care Conference On March 7th "PR Newswire (US)" - 3/1/2016 8:00:00 AM
Mast Announces Amendment To Loan And Security Agreement With Hercules Capital "PR Newswire (US)" - 2/29/2016 8:00:00 AM
Mast Therapeutics Completes Patient Enrollment In Pivotal Phase 3 "EPIC" Study For The Treatment Of Sickle Cell Crisis "PR Newswire (US)" - 2/22/2016 5:00:00 AM
Mast Therapeutics Closes $8 Million Public Offering "PR Newswire (US)" - 2/16/2016 4:15:00 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/12/2016 1:20:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/11/2016 6:14:49 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/11/2016 6:14:10 AM
Mast Therapeutics Announces Pricing Of Underwritten Public Offering "PR Newswire (US)" - 2/10/2016 9:09:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/9/2016 5:31:33 PM
Mast Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants "PR Newswire (US)" - 2/9/2016 4:23:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2016 3:35:19 PM
Mast Therapeutics To Present At 2016 BIO CEO & Investor Conference On February 8th "PR Newswire (US)" - 2/2/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/1/2016 5:18:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/1/2016 9:21:26 AM
Mast Therapeutics' AIR001 Selected By The Heart Failure Clinical Research Network For Evaluation In A 100-Patient Multicenter... "PR Newswire (US)" - 2/1/2016 9:10:00 AM
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist